Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Consolidated Statements of Cash Flows (Unaudited)

v3.23.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities    
Net loss $ (108,118) $ (26,584)
Adjustments to reconcile net loss to net cash used in operating activities:    
Impairment of other long-lived assets 4,471 3,865
Depreciation and amortization 37,198 44,451
Stock-based compensation 23,744 24,755
Foreign currency transaction loss 4,087 13,978
Gain from deconsolidation of subsidiary (39,136)
Share in losses of associated companies 11,866 2,089
Revaluation of investments 5,681 3,217
Other non-cash items, net 2,494 826
Change in cash attributable to changes in operating assets and liabilities:    
Accounts receivable, net (19,676) (21,832)
Inventories (752) (64,286)
Other current assets and prepaid expenses (3,512) 3,898
Other non-current assets 4,198 (17,003)
Accounts payable (13,031) 17,286
Other current liabilities (2,967) 2,013
Deferred revenues 5,123 4,860
Deferred income taxes, net and uncertain tax positions 2,891 (301)
Other non-current liabilities (7,609) (9,385)
Net cash used in operating activities (53,912) (57,289)
Cash flows from investing activities    
Cash paid for acquisitions, net of cash acquired (68,360)
Purchase of property and equipment (8,816) (11,761)
Investments in short-term bank deposits (31,448) (307,485)
Proceeds from short-term bank deposits 128,815 368,429
Purchase of intangible assets (1,487) (5,980)
Other investing activities (1,585) 84
Investments in unconsolidated entities (6,274) (67,274)
Net cash provided by (used in) investing activities 10,845 (23,987)
Cash flows from financing activities    
Proceeds from exercise of stock options 10 260
Payment of contingent consideration (906) (1,386)
Other financing activities (188) (281)
Net cash used in financing activities (1,084) (1,407)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (1,703) (9,787)
Net change in cash, cash equivalents and restricted cash (45,854) (92,470)
Cash, cash equivalents and restricted cash, beginning of period 150,686 243,293
Cash, cash equivalents and restricted cash, end of period 104,832 150,823
Non-cash investing and financing activities    
Transfer of inventory to fixed assets 7,316 6,306
Transfer of fixed assets to inventory 118 123
Issuance of Common stock under employee stock purchase plan 3,014
Issuance of shares as part of Covestro acquisition 5,201
Contingent consideration 2,794
Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets:    
Cash and cash equivalents 104,563 150,672
Restricted cash included in other current assets 269 151
Total cash, cash equivalents and restricted cash shown in the consolidated statement of cash flows $ 104,832 $ 150,823